Zobrazeno 1 - 10
of 456
pro vyhledávání: '"tralokinumab"'
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 791-799 (2024)
Luca Potestio,1,* Cataldo Patruno,2,* Stefano Dastoli,2 Claudio Brescia,1 Maddalena Napolitano1 1Section of Dermatology Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 2Department of Health Scienc
Externí odkaz:
https://doaj.org/article/8abd89b787e64fcab5ab465049855f70
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/49ce2f36302949ee9144026b5d37483e
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundTralokinumab, a humanized monoclonal antibody targeting interleukin-13, has been primarily used for the treatment of moderate-to-severe atopic dermatitis. Given its extensive use in clinical practice, understanding its safety profile in the
Externí odkaz:
https://doaj.org/article/07d88359576d4bb08464f1b3a87f8b3f
Autor:
Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 4, Pp 983-992 (2024)
Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their effi
Externí odkaz:
https://doaj.org/article/effdcf10082344f191430a55ef10e778
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 1, Pp 296-300 (2024)
Abstract Atopic dermatitis (AD) is an inflammatory chronic recurrent skin condition that causes recurrent, itching eczematous lesions with a great impact on the quality of life of patients. We describe a case series of five adult patients with severe
Externí odkaz:
https://doaj.org/article/b4ab2599086e4138b8b0af19f1f9a374
Autor:
Giovanni Paolino, Alessandra Narcisi, Andrea Carugno, Piergiorgio Malagoli, Matteo R. Di Nicola, Antonio Foti, Vittoria G. Bianchi, Andrea Gustavo Locatelli, Paolo Sena, Antonio Costanzo, Santo R. Mercuri, Mario Valenti
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground Genital involvement in atopic dermatitis(AD) can have a significant impact on the patient’s quality of life. However, inspection of genital areas is not usually conducted during routine examination and patients may be reluctant t
Externí odkaz:
https://doaj.org/article/26d1f396e50e419489fd7726204e9201
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground: Injection site reaction (ISR) is a local phenomenon defined as a constellation of symptoms, including swelling, erythema, pruritus, and pain around the site of injection.Objective: ISR is reported as a frequent adverse event after
Externí odkaz:
https://doaj.org/article/347baf7508444a9d89b8c01af9393dec
Autor:
Annunziata Dattola, Martina Tolone, Emanuele Amore, Luigi Bennardo, Simone Amato, Teresa Grieco, Antonio Giovanni Richetta, Giovanni Pellacani, Nevena Skroza, Steven Paul Nisticò
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024)
Introduction: The advent of biotechnological drugs has significantly changed the management of atopic dermatitis (AD) and the approach to the moderate-to-severe form of this chronic relapsing disease. Objectives: The aim of our review is to summari
Externí odkaz:
https://doaj.org/article/ca7ce1e99b07470987c1f55e9810114c
Autor:
Steven J Edwards, Charlotta Karner, Tracey Jhita, Samantha Barton, Gemma Marceniuk, Zenas Z N Yiu, Miriam Wittmann
Publikováno v:
Health Technology Assessment, Vol 28, Iss 04 (2024)
Background Atopic dermatitis is a chronic relapsing inflammatory skin condition. One of the most common skin disorders in children, atopic dermatitis typically manifests before the age of 5 years, but it can develop at any age. Atopic dermatitis is c
Externí odkaz:
https://doaj.org/article/1274ca3c50664411bbcdcb771f3d276b
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Purpose: Although psoriasis and atopic dermatitis (AD) were for decades considered to be opposing diseases, it is now known that these skin conditions can coexist or even overlap in the same individual. Especially when using modern drugs with targete
Externí odkaz:
https://doaj.org/article/4bbc7b386d2f423fa4569c9792c34987